Optimising bronchoalveolar lavage: lessons from alpha-1 antitrypsin deficiencyTHORAXIF7.72024-11-251OAAI
The impact of mannose-binding lectin (MBL) deficiency on bronchiectasis in Alpha-1 Antitrypsin DeficiencyEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Delayed Tuberculosis Paradoxical Reaction Associated with Tumor Necrosis Factor InhibitorsAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42024-10-150PRE
Reply to Chan: Identification of Alpha-1 Antitrypsin-Deficient Subjects with Normal Spirometry Who May Benefit from Alpha-1 Antitrypsin ReplacementAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42024-04-150PRE
Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi*ZZ)CLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122024-02-012OAAI
Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry AnalysisAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42023-11-0115OAAI
Augmentation therapy for severe alpha-1 antitrypsin deficiency improves survival but is decoupled from FEV1 declineEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Long-term follow-up of Pi*ZZ alpha-1 antitrypsin deficient patients receiving intravenous alpha-1 antitrypsin augmentation therapyEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Optimising research bronchoalveolar lavage in COPD and alpha-1 antitrypsin deficiencyEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 anti-trypsin for ARDS secondary to COVID-19MEDIF11.82022-04-0117OAAI
Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective thresholdEUROPEAN RESPIRATORY JOURNALIF212021-06-2514OA